VILAR E , GRUBER S B . Microsatellite instability in colorectal cancer-the stable evidence [J ] . Nat Rev Clin Oncol , 2010 , 7 ( 3 ): 153 - 162 . DOI: 10.1038/nrclinonc.2009.237 http://doi.org/10.1038/nrclinonc.2009.237

中国临床肿瘤学会结直肠癌专家委员会 , 中国抗癌协会大肠癌专业委员会遗传学组 , 中国医师协会结直肠肿瘤专业委员会遗传专委会 . 结直肠癌及其他相关实体瘤微卫星不稳定性检测中国专家共识 [J ] . 中华肿瘤杂志 , 2019 . 41 ( 10 ): 734 - 741 .

The Colorectal Cancer Expert Committee of Chinese Society of Clinical Oncology, the Genetics Group of the Colorectal Cancer Professional Committee of China Anti-Cancer Association, and the Genetics Committee of the Colorectal Cancer Professional Committee of Chinese Medical Doctor Association . Consensus on the detection of microsatellite instability in colorectal cancer and other related solid tumors in China [J ] . Chin J Oncol , 2019 . 41 ( 10 ): 734 - 741 .

黎相照 , 刘焕娇 , 梁敏仪 , 等 . 微卫星不稳定性类型及临床病理特征:基于1394例结直肠癌患者的标本检测 [J ] . 南方医科大学学报 , 2020 , 40 ( 11 ): 1645 - 1650 . DOI: 10.12122/j.issn.1673-4254.2020.11.17 http://doi.org/10.12122/j.issn.1673-4254.2020.11.17

LI X Z , LIU H J , LIANG M Y , et al. Clinicopathological features and types of microsatellite instability in 1394 patients with colorectal cancer [J ] . J South Med Univ , 2020 , 40 ( 11 ): 1645 - 1650 .

DIENSTMANN R , VERMEULEN L , GUINNEY J , et al. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer [J ] . Nat Rev Cancer , 2017 , 17 ( 2 ): 79 - 92 . DOI: 10.1038/nrc.2016.126 http://doi.org/10.1038/nrc.2016.126

GROTHEY A , FAKIH M , TABERNERO J . Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines [J ] . Ann Oncol , 2021 , 32 ( 8 ): 959 - 967 . DOI: 10.1016/j.annonc.2021.03.206 http://doi.org/10.1016/j.annonc.2021.03.206

Chinese Society of Clinical Oncology Diagnosis and Treatment Guidelines for Colorectal Cancer Working Group . Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version) [J ] . Chin J Cancer Res , 2019 , 31 ( 1 ): 117 - 134 .

OLIVEIRA A F , BRETES L , FURTADO I . Review of PD-1/PD-L1 inhibitors in metastatic dMMR/MSI-H colorectal cancer [J ] . Front Oncol , 2019 , 9 : 396 . DOI: 10.3389/fonc.2019.00396 http://doi.org/10.3389/fonc.2019.00396

SARIDAKI Z , SOUGLAKOS J , GEORGOULIAS V . Prognostic and predictive significance of MSI in stages Ⅱ/Ⅲ colon cancer [J ] . World J Gastroenterol , 2014 , 20 ( 22 ): 6809 - 6814 .

HESTETUN K E , ROSENLUND N B , STANISAVLJEVIĆ L , et al. Stage-dependent prognostic shift in mismatch repair-deficient tumors: assessing patient outcomes in stage Ⅱ and Ⅲ colon cancer [J ] . Front Oncol , 2022 , 12 : 853545 .

FUJIYOSHI K , YAMAMOTO G , TAKENOYA T , et al. Metastatic pattern of stage Ⅳ colorectal cancer with high-frequency microsatellite instability as a prognostic factor [J ] . Anticancer Res , 2017 , 37 ( 1 ): 239 - 247 .

LOUPAKIS F , CREMOLINI C , MASI G , et al. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer [J ] . N Engl JMed , 2014 , 371 ( 17 ): 1609 - 1618 .

MAURI G , BONAZZINA E , AMATU A , et al. The evolutionary landscape of treatment for BRAF V600E mutant metastatic colorectal cancer [J ] . Cancers , 2021 , 13 ( 1 ): 137 .

GUINNEY J , DIENSTMANN R , WANG X , et al. The consensus molecular subtypes of colorectal cancer [J ] . Nat Med , 2015 , 21 ( 11 ): 1350 - 1356 . DOI: 10.1038/nm.3967 http://doi.org/10.1038/nm.3967

JOANITO I , WIRAPATI P , ZHAO N , et al. Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer [J ] . Nat Genet , 2022 , 54 ( 7 ): 963 - 975 .

郑民华 , 张森 , 马君俊 . 结直肠癌的分子分型与精准治疗策略:从经验到精确 [J ] . 中华消化外科杂志 , 2023 , 22 ( 10 ): 1155 - 1159 .

ZHENG M H , ZHANG S , MA J J . Molecular typing and precise treatment strategies for colorectal cancer: from experience to precision [J ] . Chin j Dig Surg , 2023 , 22 ( 10 ): 1155 - 1159 .

LIU Q , LUO D K , CAI S J , et al. P-TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management [J ] . Cancer Manag Res , 2018 , 10 : 2303 - 2314 . DOI: 10.2147/CMAR.S165188 http://doi.org/10.2147/CMAR.S165188

HATCH S B , LIGHTFOOT H M JR , GARWACKI C P , et al. Microsatellite instability testing in colorectal carcinoma: choice of markers affects sensitivity of detection of mismatch repair-deficient tumors [J ] . Clin Cancer Res , 2005 , 11 ( 6 ): 2180 - 2187 . DOI: 10.1158/1078-0432.CCR-04-0234 http://doi.org/10.1158/1078-0432.CCR-04-0234

COLLE R , LONARDI S , CACHANADO M , et al. BRAF V600E/RAS mutations and Lynch syndrome in patients with MSI-H/dMMR metastatic colorectal cancer treated with immune checkpoint inhibitors [J ] . Oncologist , 2023 , 28 ( 9 ): 771 - 779 . DOI: 10.1093/oncolo/oyad082 http://doi.org/10.1093/oncolo/oyad082

VENDERBOSCH S , NAGTEGAAL I D , MAUGHAN T S , et al. Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies [J ] . Clin Cancer Res , 2014 , 20 ( 20 ): 5322 - 5330 . DOI: 10.1158/1078-0432.CCR-14-0332 http://doi.org/10.1158/1078-0432.CCR-14-0332

AASEBØ K Ø , DRAGOMIR A , SUNDSTRÖM M , et al. Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: a population-based cohort of metastatic colorectal cancer patients [J ] . Cancer Med , 2019 , 8 ( 7 ): 3623 - 3635 .

杨利华 , 杨树东 . RAS 、 BRAF 基因突变及HER2基因扩增与结直肠癌患者临床病理特征及预后的关系 [J ] . 中华普通外科杂志 , 2022 , 37 ( 11 ): 845 - 849 .

YANG L H , YANG S D . Relationship between RAS , BRAF gene mutations and HER2 gene amplification and clinicopathology and prognosis of colorectal cancer [J ] . Chin J Gen Surg , 2022 , 37 ( 11 ): 845 - 849 .

YAEGER R , CERCEK A , CHOU J F , et al. BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer [J ] . Cancer , 2014 , 120 ( 15 ): 2316 - 2324 .

TAIEB J , SVRCEK M , COHEN R , et al. Deficient mismatch repair/microsatellite unstable colorectal cancer: diagnosis, prognosis and treatment [J ] . Eur J Cancer , 2022 , 175 : 136 - 157 . DOI: 10.1016/j.ejca.2022.07.020 http://doi.org/10.1016/j.ejca.2022.07.020

NAKAYAMA I , HIROTA T , SHINOZAKI E . BRAF mutation in colorectal cancers: from prognostic marker to targetable mutation [J ] . Cancers , 2020 , 12 ( 11 ): 3236 .

KARKI S , SUN W J , MADAN R , et al. Microsatellite instability with BRAF V600E associated with delayed presentation but poor survival in stage Ⅲ colorectal cancer [J ] . Fortune J Health Sci , 2023 , 6 ( 2 ): 167 - 173 .

DIAZ L A JR , SHIU K K , KIM T W , et al. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study [J ] . Lancet Oncol , 2022 , 23 ( 5 ): 659 - 670 . DOI: 10.1016/S1470-2045(22)00197-8 http://doi.org/10.1016/S1470-2045(22)00197-8

DING Y W , WENG S S , LI X Y , et al. General treatment for metastatic colorectal cancer: from KEYNOTE 177 study [J ] . Transl Oncol , 2021 , 14 ( 8 ): 101122 .

JOHNSON B , KOPETZ S . Applying precision to the management of BRAF-mutant metastatic colorectal cancer [J ] . Target Oncol , 2020 , 15 ( 5 ): 567 - 577 .